INNOSCIENCE (02577) elects Weiwei Luo as Chairman
INNOSCIENCE (02577) announced that the term of the Company's first Board of Directors has expired. In accordance with the relevant provisions of the Company Law and the Articles of Association, the Company held an employee representative meeting on September 23, 2026, at which Mr. Wu Lei was elected as an employee representative director of the second Board of Directors. Mr. Wu Lei, together with the other 8 non-employee representative directors elected at the extraordinary general meeting, will jointly constitute the second Board of Directors, with a term consistent with that of the second Board of Directors.
INNOSCIENCE (02577) announces that the term of the first board of directors of the Company has expired. In accordance with the relevant provisions of the Company Law and the Articles of Association, the Company held an employee representative meeting on September 23, 2026, at which Mr. Wu Lei was elected as an employee representative director of the second board of directors. Mr. Wu Lei, together with the other 8 non-employee representative directors elected at the extraordinary general meeting, will jointly constitute the second board of directors, with a term consistent with that of the second board of directors.
In accordance with the relevant provisions of the Company Law, the Articles of Association and the Listing Rules, the first meeting of the second board of directors was held on September 23, 2026, at which Dr. Weiwei Luo was elected as the chairman of the second board of directors, with a term commencing from the date of approval by the board of directors and ending on the date of expiration of the second board of directors.
Related Articles

Sunflower Pharmaceutical Group (002737.SZ) plans to acquire 100% equity of Dongxu Pharmaceutical.

GOFINTECH QUANT (00290) grants a total of 74.192 million share awards.

TIAN TU CAPITAL (01973): Subsidiary intends to subscribe for equity interests in Topos AI Infra Holdings and Topos AI Infra Investments, with a total commitment of US$25 million.
Sunflower Pharmaceutical Group (002737.SZ) plans to acquire 100% equity of Dongxu Pharmaceutical.

GOFINTECH QUANT (00290) grants a total of 74.192 million share awards.

TIAN TU CAPITAL (01973): Subsidiary intends to subscribe for equity interests in Topos AI Infra Holdings and Topos AI Infra Investments, with a total commitment of US$25 million.






